The collection and dissemination of data on human and non-human organisms has become a central feature of 21 st century biology and has been endorsed by funding agencies in the United States and Europe as crucial to translating biological research into therapeutic and agricultural innovation. Large molecular datasets, often referred to as 'big data', are increasingly incorporated into digital databases, many of which are freely accessible online.
This methodological, conceptual and institutional shift in the scientific status of data is particularly visible within biology and biomedicine, where the emergence of 'big data' in the form of large molecular datasets (generated through new technologies such as sequencing machines and microarray experiments) has developed hand in hand with an ethos of data sharing. Indeed, the widespread sharing advocated by the Open Data movement has also long been supported by biologists working on key non-human organisms for molecular research, such as the fruit-fly Drosophila melanogaster (Kohler 1994 , Leonelli and Ankeny 2012 , Kelty 2012 . Further, prominent biomedical researchers such as Francis Collins (who used to direct the Human Genome Project and now heads the National Institute of Health) have forcefully argued against the privatization of human genomic data, for instance by underwriting international agreements to release sequence data as soon as it is produced. 1 Over the last decade, funding agencies such as the National Institute of Health, National Science Foundation, European Research Council and Research Councils UK have strongly endorsed this innovative perception of how data should be managed. They are actively promoting Open Data as key to the advancement of basic research and its translation into applications with immediate social impact, such as therapeutic or agricultural innovations. 2 In practice, this means that they are pressuring their grantees to release data to public databases -a move that in turn affects how scientists set up their research and how they measure and develop their outputs. Many researchers now invest considerable time and resources into donating data to public repositories; and regard the consultation of online databases as a first and crucial step towards the development of new lines of inquiry.
1 One well-known example of such agreements are the so-called Bermuda Rules (Harvey and McMeekin 2007; see also ongoing research by Rachel Ankeny and Robert Cook-Deegan). 2 These shifts in science policy are evidenced by the recommendations of the National Working Group on Expanding Access to Published Research Findings in the UK, also known as the Finch Report, and the subsequent statement by Research Councils UK, both from 2012.
An important question to raise vis-à-vis these scientific developments, which also helps to decipher their significance to global civil society at large, concerns the reasons why the Open Data movement has acquired such prominence in contemporary scientific and public discourse. Given the enormous achievements of 20 th century science, where data sharing was confined to small sections of the (predominantly Western) scientific community, why are funding bodies insisting on Open Data as crucial to 21 st century research? This is the central question that I wish to address in this paper. A standard answer to this question, often endorsed by journalistic accounts of the power and promise of 'big data', points to Open Data as a crucial way for scientists to exploit the emergence of new technologies, such as genome sequencing and internet-based social media. It is certainly true that the availability and widespread uptake of new information and communication technologies, as well as the introduction of new methods of data generation, play a crucial role in making it possible to produce and share information on the scale advocated by the Open Data movement. And yet, I believe that the emergence and political impact of the Open Data movement are not a mere consequence of technological advances in data production and communication, nor are its implications restricted solely to science.
In what follows, I argue that the scientific concerns underlying the Open Data movement need to be evaluated in relation to at least four other sets of factors. First, Open Data provides a common platform for scientists, scientific institutions and funders (in both the private and the public sphere) to discuss and tackle the practical difficulties involved in making data travel and be re-used. Second, it feeds into concerns with transparency, legitimacy and return on investment on the part of science policy and funding bodies. Third, it aligns with the challenges posed by the globalization of biomedical research to new parts of the world, and the resulting infrastructural fragmentation and geographical dispersion of research processes.
And forth, it exemplifies the embedding of scientific research in market logics and contexts.
To make it at all feasible for data to travel, market structures and political institutions need to assess not only their scientific value, but also their value as political, financial and social objects: the increased mobility of data is unavoidably tied to their commodification. Thus, not only does the widespread dissemination of biomedical data challenge established ways to produce, control and use scientific knowledge; it also plays a key role in mediating global market exchange and international politics, thus achieving a prominent social and economic significance well beyond science itself.
A critical assessment of the significance of the Open Data movement for contemporary society at large needs to take account of all these factors, which foreground the indissoluble ties of scientific research to global political economy. I shall now briefly discuss each set of factors with reference to recent developments in biological and biomedical research.
Let us start from the importance of bringing together a variety of stakeholders to tackle the difficulties involved in making data travel. The fact that data are produced by a variety of groups, for different purposes, in different parts of the world poses immense scientific, logistical, ethical and structural challenges to their open dissemination. Whether scientific data are shared, among whom and to which effect depends on the existence of appropriate regulatory, social and material infrastructures, such as (1) workable databases, guidelines on data donation, and servers located in safe locations where data storage can be guarantee in the long term; as well as (2) well-coordinated networks of individuals, scientific groups, companies and institutions that take responsibility for developing, financing and enforcing those infrastructures and the related instruments, computers and software (Hilgartner 1995; Leigh Star 1996; Bowker 2001; Hine 2006 ; Edwards 2010; Leonelli 2010a/b).
Virtually every area of biological and biomedical investigation is in need of dedicated databases, which are specifically targeted to collecting and visualizing the varieties of data involved in each field. For instance, cancer research requires the integration of genetic, physiological and clinical data, as well as data coming from non-human organisms such as mice. Providing common access to such diverse datasets is a complex requirement involving the coordination of several stakeholders in cancer research, ranging from individual research laboratories to pharmaceutical industries, governmental agencies, hospitals and public health services. Even well-funded attempts such as the Cancer Bioinformatics Grid have struggled to coordinate such an extensive and varied group.
In response to the technical demands involved in these efforts, companies like IBM and leading universities such as Harvard and MIT are training a whole new cluster of 'data scientists' specializing in the construction of data infrastructure. Data scientists need to combine knowledge of specific areas of the life sciences (such as genetics or cell biology) with skills in bioinformatics and computer science -a new set of skills which makes the curation of data, hitherto seen as a technician's job, into a branch of scientific research in its own right (Hilgartner 1995; Lenoir 1999; Hine 2006; Leonelli 2009b Leonelli , 2010b Leonelli , 2012a .
However, this approach requires institutional and financial backing, in order to guarantee that data scientists have the status and power needed to develop and implement their contributions. This is hardly surprising when looking at previous examples of such efforts in the history of science: there are well-documented cases of data infrastructures that were unable, in the longer term, to co-ordinate the diversity of interests, values, terminologies and constraints involved in the relevant research areas, as well as to muster enough financial and human resources to support themselves. 3 The resources and skills required to achieve such coordination are clearly not only technical, but also social (Leonelli 2009b (Leonelli , 2010b . Thus, many scientific institutions are thus incorporating mechanisms to recognize and reward the contributions of data scientists.
Industries are also increasingly supporting bioinformaticians as key contributors to R&D; and the publishing industry is trialing new types of journal devoted to documenting data dissemination strategies (e.g. GigaScience, started in 2012).
These new infrastructures are in turn embedded within wider political and economic contexts, which brings me to the second set of factors underlying the current push towards Open Data: the emphasis placed by public institutions responsible for science funding, often under pressure from national and international policy, on fostering public trust in science as a source of reliable knowledge and thus as a legitimate source of information.
Promoting the transparency and accessibility of science is particularly important in the face of its technical nature, which makes it hard to comprehend for the vast majority of citizens, and the disillusionment surrounding technoscientific achievement in the West. Cases in point are the controversies raging over the safety of genetically modified foods in Europe, or the recent criminalisation of earthquake specialists in Italy, accused of failing to predict the 2009 devastation of the city of L'Aquila. Perhaps the most blatant recent case of public mistrust in science is the controversy following the public release of emails exchanged by researchers at the Climatic Research Unit of the University of East Anglia in 2010 (an episode often referred to as ClimateGate). This was a case where a perceived lack of transparency in how climate data were handled fuelled social mistrust in the scientific consensus on global warming, which in turn affected public support for the implementation of international measures against climate change. Many national governments and international organisations like the European Research Council support the free circulation of data in the hope that it will increase the transparency and accountability of scientific research -and thus, potentially, its trustworthiness and social legitimacy. Similarly, the Royal Society has pointed to Open Data as an opportunity to prevent scientific fraud and disclose the evidence base for scientific pronouncements to the general public, so as to avoid the kind of miscommunication and misunderstanding underlying ClimateGate.
The increasing reliance on and support for online data dissemination is also intimately related to the globalisation of science beyond traditional centres of Euro-American power (my third point). Open Data are implicated in transforming the geographies of science and its relation to local economies, as illustrated by the rise of centres of biomedical research excellence in the Global South. Centres such as the Beijing Genomics Institute, one of the powerhouses of contemporary data production in biomedicine, interact with researchers across the globe largely through digital means, and do not see themselves as requiring the support of extensive local or even national research infrastructure and traditions. Thanks to widespread data dissemination over the internet, they can quickly learn from results produced elsewhere and contribute their own share of data to international databases and research projects, thus gaining visibility and competing with established programmes in the United States, Japan and Europe. Nations that have not figured as prominent producers of scientific knowledge throughout the 20 th century, such as China and Singapore, are thus devoting increasing financial support to research, in the hope to attract a highly skilled workforce and boost their industrial productivity and economic prospects.
The conditions of possibility for data sharing, and the diverse motivations, stakes and incentives underlying data donation to online databases, illustrate how widespread data dissemination has created new forms of inclusion and exclusion. One might think that laboratories in poor or underfunded regions would strongly support data sharing, for it makes data produced with expensive technology accessible to them, thus raising their chance to produce cutting-edge science; and that rich laboratories, which regard the possession of such technologies as providing them with a competitive edge, would be reluctant to donate dataparticularly since donation requires additional labour. However, taking account of the considerable resources and diverse expertise needed to transform data into new knowledge helps to acquire a more realistic view on the benefits and costs of data sharing. Underfunded laboratories actually struggle to access online resources, appropriate bandwidth, adequate expertise and computers powerful enough to analyse data found online; and are coming to terms with the difficulties involved in developing resources and standards for data donation.
By contrast, many rich laboratories have found that data donation offers the opportunity to participate in international networks and receive help with data analysis, thus accruing their own prestige, visibility and productivity. Even major pharmaceutical companies like GlaxoSmithKline and Syngenta are contributing to the development of public databases, in the hope of outsourcing their R&D efforts, improve their public image and gaining from the availability of data produced through public funding.
This brings me to the last set of factors that I wish to discuss as relevant to explaining the prominence of Open Data as a contemporary social and scientific movement. This is the extent to which data dissemination practices are embedded into global political economies.
The very idea of scientific data as artefacts that can be traded, circulated across the globe and re-used to create new forms of value is indissolubly tied to market logics, with data figuring as objects of market exchange. National governments and industries that have invested heavily on data production -through the financing of clinical trials or genome sequencing projects -are keen to see results. This requirement to maximise returns from past investments, and the urgency typically attached to it, fuels the emphasis on data needing to travel widely and fast to create knowledge that would positively impact human health. This is particularly evident when considering the extraordinary expectations linked to the Human Genome Project and its potential to contribute to medical advances. Indeed, it could be argued that the allure of 'big data' lies precisely in the impossibility to predict and quantify their potential as evidence in advance. This makes it possible to inflate or deflate expectations to suit the dynamics of venture capitalism, while at the same time respecting the methods and ultimate goals of the scientific effort at hand. If we were able to predict exactly how a specific dataset could be used in the future, and thus which data should or not be widely disseminated, we would not need Open Data in the first place: the point of free and widespread data dissemination is that one never knows who might be able to view which data and see something new in them, or indeed whether such fruitful use of data is at all possible. 4
As exemplified by Mike Fortun's 2008 analysis of the DECODE case, the opportunity to circulate and re-interpret data is unavoidably couched in vastly promissory terms, and it is hard to differentiate a priori between a fruitful data sharing initiative and one that is unlikely to yield scientific insight -which makes financial investments in this area both risky and potentially rewarding.
Further, the open dissemination and re-use of data does not only challenge notions of competition and property within established scientific communities, but also notions of property, privacy and effective communication in industry, government and civil society.
Data acquired from patients in clinical trials or participants in personalised genomics, for instance, have clear economic value, and many pharmaceutical companies welcome the opportunity to access personal information unwittingly circulated by citizens who are not aware of its value as 'data' for medical research -a move widely disputed by legal scholars, advocacy groups and medical associations as an infringement of privacy (Tutton and Prainsack 2011). The dissemination of data of relevance to innovation in food security or bioenergy, such as molecular data on plants and plant pathogens, is similarly plagued by uncertainties about intellectual property, particularly in cases of public-private partnerships between governmental agencies and companies such as Monsanto or Shell. It is yet unclear how fundamentally data sharing will transform industrial practices and relations to intellectual property, but it is notable that such an option is being actively considered.
Kaushik Sunder Rajan (2006) and Chris Kelty (2008) have shown how free data access has greatly helped to maximise exchange and downstream capital flows. At the same time, data mobility is not free in the sense of being devoid of financial and social costs. Data sharing requires human resources and capital: even the most successful initiatives are confronted with the exponential costs involved in maintaining and expanding data infrastructures in the longterm, and are struggling to produce sustainable business plans for their activities (Bastow and Leonelli 2010) . Indeed, the European Union has denounced the costs associated with funding the current plurality of online databases in biomedicine as unsustainable in the long term, and is pushing for the centralisation of facilities for data sharing as a possible solution (most prominently through ELIXIR, a gigantic effort currently underway at the European Bioinformatics Institute to coordinate and eventually integrate data sharing initiatives in biology and medicine; see the ELIXIR website: http://www.elixir-europe.org/ ). The National Science Foundation, which has funded many successful data sharing initiatives at the turn of the millennium, is also attempting to rationalise its investments in this area and is now asking database curators to provide self-sustaining business models (e.g. Bastow et al 2010).
To conclude: the emergence of technologies that facilitate the production and dissemination of biological data on a large scale is certainly a key reason for the visibility and political support garnered by the Open Data movement in recent years. Further, adequate expertise and infrastructures are needed to assess the reliability and potential significance of data, thus ensuring that data journeys can contribute to the development of knowledge perceived to be relevant and useful within a variety of domains. In turn, the development of technologies and expertise for the care of data, not to mention their production and use to create new biomedical knowledge and interventions, is made possible by the availability of institutions that help to define the financial value of data as commodities and the conditions under which data can be made to travel around the globe.
What has propelled data into becoming protagonists of contemporary biomedicine is their ambiguous status as at once local and global, free commodities and strategic investments, common goods and grounds for competition, potential evidence and meaningless information. Openness, defined through the opportunities for dissemination associated with the internet, is a defining characteristic of 'big data' science, policy and infrastructure. The vision underlying the Open Data movement is that data risk to remain meaningless if they are prevented from travelling far and wide, and that travel endows data with multiple forms of scientific as well as financial, social and political value. This flexibility to multiple uses and future scenarios, as well as to the diverging interests of potential users, is crucial to a contemporary biomedicine that is concerned with movement, and which sees the constant rearticulations of knowledge to and through value. 5
